SARS-CoV-2 ferritin nanoparticle vaccines elicit broad SARS coronavirus immunogenicity

Document Details

Document Type
Pub Defense Publication
Publication Date
Dec 01, 2021
Source ID
10.1016/j.celrep.2021.110143

Entities

People

  • Agnes Hajduczki
  • Akshaya Ganesh
  • Alexander Q Anderson
  • Aslaa Ahmed
  • Caitlin Kuklis
  • Caroline E. Peterson
  • Chandrika B. Kannadka
  • Christopher P. Karch
  • Clayton Smith
  • Connor Whalen
  • David Mccurdy
  • Debra K. Duso
  • Elaine B. Morrison
  • Elizabeth J. Martinez
  • Gary R Matyas
  • Gregory D. Gromowski
  • Htet Khanh
  • James Brett Case
  • Jeffrey R. Currier
  • Jiae Kim
  • Joshua M. Carmen
  • Kayvon Modjarrad
  • Larry W. Kummer
  • Letzibeth Mendez-rivera
  • Lindsay Wieczorek
  • Lorean Rosado
  • M Gordon Joyce
  • Mangala Rao
  • Mark T Esser
  • Matthew A. Cole
  • Michael S. Diamond
  • Michelle Zemil
  • Misook Choe
  • Morgane Rolland
  • Natalia de Val
  • Neelakshi Gohain
  • Nelson Michael
  • Ousman Jobe
  • Patrick M. Mctamney
  • Paul V. Thomas
  • Rajeshwer S. Sankhala
  • Rita E. Chen
  • Sandrine Soman
  • Saravanan Rajan
  • Sebastian Molnar
  • Shania E. Muncil
  • Shelly J. Krebs
  • Shikha Shrivastava
  • Therese Oertel
  • Tricia J. Lang
  • Ursula Tran
  • Victoria R. Polonis
  • Vincent Dussupt
  • Wei-hung Chen
  • Weimin Wu
  • William C Chang
  • William W. Reiley
  • Yifan Li
  • Zoltan Beck
  • Zuzana Villar

Organizations

  • National Institutes of Health
  • United States Department of Defense

Tags

Technology Areas

  • Biotechnology